Polpharma Biologics

Polpharma Biologics company information, Employees & Contact Information

Our mission is to create quality biologics with a passion to improve the lives of patients. Polpharma Biologics is an international biotechnology company with integrated operations in the European Union (EU), developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production preparing drugs for future commercial partnerships with global pharmaceutical players. The company’s expertise is in the development and manufacturing of medicines based on microbial and mammalian expression systems. With its cell line development center in Netherlands and two centers of development and manufacturing in Poland, Polpharma Biologics creates growth and development opportunities for biotechnology specialists. Find out more at our website

Company Details

Employees
1.06K
Address
Ulica Trzy Lipy 3, Poland
Phone
48 58 770 95 00
Email
of****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Gdańsk, Pomorskie
Looking for a particular Polpharma Biologics employee's phone or email?

Polpharma Biologics Questions

News

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars - Yahoo Finance

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars Yahoo Finance

Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development - PR Newswire

Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development PR Newswire

Polpharma Biologics secures distribution of upcoming biosimilars - European Biotechnology Magazine

Polpharma Biologics secures distribution of upcoming biosimilars European Biotechnology Magazine

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016 - Yahoo Finance

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016 Yahoo Finance

Polpharma Biologics Announces Rebrand and Launch of New Value “We Care” as 2000 L Bioreactors Begin Validation at Its Warsaw Site - Business Wire

Polpharma Biologics Announces Rebrand and Launch of New Value “We Care” as 2000 L Bioreactors Begin Validation at Its Warsaw Site Business Wire

Top Polpharma Biologics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant